Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Mitsubishi Tanabe Pharma Europe Ltd, Dashwood House, 69 Old Broad Street, London EC2M 1QS, United Kingdom
Exembol 1 mg/ml Solution for Infusion.
| Pharmaceutical Form |
|---|
|
Solution for Infusion. Clear colourless to pale yellow solution. The pH of the intravenous solution is 5.0–8.0. |
One ml solution for infusion contains 1 mg argatroban monohydrate.
One vial with 50 ml solution for infusion contains 50 mg argatroban monohydrate.
Excipients: 1 ml of solution for infusion contains 4 mg ethanol (0.5% by volume), 3 mg sorbitol (E420 i) and 9 mg sodium chloride.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Argatroban |
Argatroban, a synthetic L-arginine derivative, is a direct thrombin inhibitor (molecular weight 526.65) that binds reversibly to thrombin. Argatroban exerts its anticoagulant effect independently of antithrombin III and inhibits fibrin formation; activation of coagulation factors V, VIII and XIII; activation of protein C; and platelet aggregation. |
| List of Excipients |
|---|
|
Sorbitol (E420i) |
Clear 50 ml glass vial sealed with an ethylene tetrafluorethylene (ETFE)-coated chlorobutyl rubber stopper and aluminium crimp-seal with a polypropylene flip-off cap. Each vial contains 50 ml of solution for infusion.
Vials are supplied in cardboard cartons of 4 or 12 vials. Not all pack-sizes may be marketed.
Mitsubishi Tanabe Pharma Europe Ltd, Dashwood House, 69 Old Broad Street, London EC2M 1QS, United Kingdom
PL 20012/0011
2015-12-31
| Drug | Countries | |
|---|---|---|
| EXEMBOL | Estonia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
